Gilhodes, J.; Meola, A.; Cabarrou, B.; Peyraga, G.; Dehais, C.; Figarella-Branger, D.; Ducray, F.; Maurage, C.-A.; Loussouarn, D.; Uro-Coste, E.;
et al. A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas. Cancers 2023, 15, 3067.
https://doi.org/10.3390/cancers15123067
AMA Style
Gilhodes J, Meola A, Cabarrou B, Peyraga G, Dehais C, Figarella-Branger D, Ducray F, Maurage C-A, Loussouarn D, Uro-Coste E,
et al. A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas. Cancers. 2023; 15(12):3067.
https://doi.org/10.3390/cancers15123067
Chicago/Turabian Style
Gilhodes, Julia, Adèle Meola, Bastien Cabarrou, Guillaume Peyraga, Caroline Dehais, Dominique Figarella-Branger, François Ducray, Claude-Alain Maurage, Delphine Loussouarn, Emmanuelle Uro-Coste,
and et al. 2023. "A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas" Cancers 15, no. 12: 3067.
https://doi.org/10.3390/cancers15123067
APA Style
Gilhodes, J., Meola, A., Cabarrou, B., Peyraga, G., Dehais, C., Figarella-Branger, D., Ducray, F., Maurage, C.-A., Loussouarn, D., Uro-Coste, E., Cohen-Jonathan Moyal, E., & POLA Network.
(2023). A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas. Cancers, 15(12), 3067.
https://doi.org/10.3390/cancers15123067
